TP53 and astrocytoma (excluding glioblastoma): Furthermore, Watanabe et al. [5] demonstrated the copresence of IDH1 and TP53 mutations in 63% of low-grade astrocytomas, whereas IDH1 mutation plus 1p/19q loss was present in most (64%) oligodendrogliomas.